Local bacteria affect the efficacy of chemotherapeutic drugs

Lehouritis, Panos, Cummins, Joanne, Stanton, Michael, Murphy, Carola T., McCarthy, Florence O., Reid, Gregor, Urbaniak, Camilla, Byrne, William L. +1 more·2015·Scientific Reports

Cited by (313)

Items 201–300 of 313

  1. Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models
    Patrik Kovács, Szandra Schwarcz, Petra Nyerges, Tímea Ingrid Bíró, Gyula Ujlaki, Péter Bai, Edit Mikó · 2024 · Frontiers in Cell and Developmental Biology
  2. NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma
    Debora Soncini, Pamela Becherini, Francesco Ladisa, Silvia Ravera, Adithya Chedere, Elisa Gelli, Giulia Giorgetti, Claudia Martinuzzi, Francesco Piacente, Luca Mastracci et al. · 2024 · Blood Advances
  3. Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components
    Sara Sofia De Lucia, Enrico Celestino Nista, Marcello Candelli, Sebastiano Archilei, Franziska Deutschbein, Enrico Capuano, Antonio Gasbarrini, Francesco Franceschi, Giulia Pignataro · 2025 · Cancers
  4. Intratumoral microbiome: a crucial regulating factor in development and progression of colorectal cancer
    Yating Fan, Xiangshuai Gu, Hua Yang, Ye Chen, Chao Fang, Hongxin Deng, Lei Dai · 2025 · Molecular Biomedicine
  5. Intestinal Flora in Chemotherapy Resistance of Biliary Pancreatic Cancer
    Liuhui Bai, Xiang-Dong Yan, Jin Lv, Ping Qi, Xiaojing Song, Lei Zhang · 2023 · Biology
  6. Intestinal microbiota, probiotics and their interactions with drugs: knowledge, attitudes and practices of health science students in Serbia
    Maja Đanić, Nikolija Marković, Tijana Ostojić, Milena Kojic, Slavica Lazarević, Momir Mikov, Nebojša Pavlović · 2024 · BMC Medical Education
  7. Efficacy of Moxifloxacin plus Treatment of Physician's Choice in Patients with Metastatic Breast Cancer
    Xinyue Wang, Jibin Li, Wei Shi, Zhangzan Huang, Wen Xia, Jiajia Huang, Yanhong Su, Shusen Wang, Yanxia Shi, Xiwen Bi et al. · 2020 · The Oncologist
  8. Microbiota and Hematological Diseases
    Guido D’Angelo · 2022 · International Journal of Hematology-Oncology and Stem Cell Research
  9. Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota
    Francesca Pirini, Michela Cortesi, Maria Maddalena Tumedei, Michele Zanoni, Sara Ravaioli, Sara Bravaccini · 2023 · Frontiers in Cell and Developmental Biology
  10. Efficacy of capecitabine when used concomitantly with proton pump inhibitors in cancer patients: a systematic review
    D. Viñal, Nuria Rodrı́guez-Salas, Pablo Pérez-Wert, Oliver Higuera, Ismael Ghanem, Jaime Feliú · 2019 · Clinical & Translational Oncology
  11. Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
    Valeria Merz, Domenico Mangiameli, Camilla Zecchetto, Alberto Quinzii, Silvia Pietrobono, Carlo G. M. Messina, Simona Casalino, Marina Gaule, Camilla Pesoni, Pasquale Vitale et al. · 2022 · Frontiers in Surgery
  12. Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
    Francesca Benedetti, Emmanuel F. Mongodin, Jonathan H. Badger, Arshi Munawwar, Ashley Cellini, Weirong Yuan, Giovannino Silvestri, Carl N. Kraus, Simone Marini, Chozha Vendan Rathinam et al. · 2024 · Journal of Translational Medicine
  13. Methods and criteria for validating the multimodal functions of perinatal derivatives when used in oncological and antimicrobial applications
    Antonietta Rosa Silini, Taja Železnik Ramuta, Ana Salomé Pires, Asmita Banerjee, Marie Dubus, Florelle Gindraux, Halima Kerdjoudj, Justinas Mačiulaitis, Adelheid Weidinger, Susanne Wolbank et al. · 2022 · Frontiers in Bioengineering and Biotechnology
  14. Advances in the Correlation between Intestinal Microbiota and Breast Cancer Development
    Yonglan Jiang, Xinping Chen, Shengmiao Fu · 2020 · Journal of Cancer Therapy
  15. Microbe defines the efficacy of chemotherapeutic drug: a complete paradigm
    P Dalal, Deepika Sharma · 2021 · FEMS Microbiology Letters
  16. Antibiotic treatment and survival in patients with resected, early-stage pancreatic ductal adenocarcinoma receiving chemotherapy
    Emma W. Gong, Daniel Jeremy Fulop, Joyce Serebrenik, Arielle J. Labiner, Deirdre Jill Cohen, Keith Magnus Sigel, Aimee Lee Lucas · 2025 · JNCI Cancer Spectrum
  17. Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer
    Reio Ueta, Hiroo Imai, Ken Saijo, Yoshifumi Kawamura, Shuto Kodera, Chikashi Ishioka · 2025 · Cancer Medicine
  18. Stimuli-responsive nanomaterials for eradicating intratumoral bacteria and augmenting tumor therapy efficiency: progress and perspectives
    Jianlin Wang, Zhenning Su, Xin Zhang, Siyu Wang, Xihua Chen, Xiangbo Xu, Bin He, Yufeng Zheng · 2025 · Biomaterials
  19. Insights Into the Relationship Between Gut Microbiota and Colorectal Cancer
    João Felipe Mota, Jens Walter, Carla Marques Maia Prado · 2018 · Current Colorectal Cancer Reports
  20. The role of the microbiota in cancer drug resistance and emerging therapeutic strategies
    Chang Che, Yelu Zhou, Liyu Chen, Sifan Li, daiming fan, Yuanyuan Lu, Xiaodi Zhao · 2026 · Cancer Letters
  21. Klebsiella pneumoniae LPS drives stromal-mediated repression of p53 and colorectal cancer chemoresistance
    Konstantinos Fragkoulis, Barbara Łasut-Szyszka, Ákos Végvári, Diyoly Ayona, Amir Ata Saei, Marie‐Stéphanie Aschtgen, Sylvain Peuget · 2026 · Cell Death and Disease
  22. Exploring the prognostic and predictive potential of bacterial biomarkers in non-gastrointestinal solid tumors
    Caoimbhe Burke, Thomas J. Glynn, Chowdhury Arif Jahangir, Clodagh L. Murphy, Niamh E. Buckley, Mark Tangney, Arman Rahman, William M. Gallagher · 2025 · Expert Review of Molecular Diagnostics
  23. The oncobiome; what, so what, now what?
    Munawar Abbas, Mark Tangney · 2025 · Microbiome Research Reports
  24. Negative Effect of Intravenous Antibiotics on Survival in Patients with Triple-Negative Breast Cancer
    Stefan Lukac, Visnja Fink, Davut Dayan, Brigitte Kathrin Rack, Wolfgang Janni, Krisztián Látó, Kristina Veselinovic, Sabine Heublein, Thomas W. P. Friedl, Elena Leinert · 2025 · Cancers
  25. Body site-dependent variations of microbiota in pancreatic cancer pathophysiology
    Concetta Panebianco, Valerio Pazienza · 2019 · Critical Reviews in Clinical Laboratory Sciences
  26. Induction of CD8 T cell cytotoxicity by fecal bacteria from healthy individuals and colorectal cancer patients
    Yanli Lu, Linlin Wang, Jian Zhang, Jun Li, Wan Guohua · 2019 · Biochemical and Biophysical Research Communications
  27. Molecular Mechanisms of Gut Microbiota-Associated Colorectal Carcinogenesis
    Yichang Shao, Xun Zeng · 2020 · Infectious Microbes & Diseases
  28. Targeting Intratumoral Bacteria for Cancer Nanotherapeutics
    Ying Wang, J. S. Yu, Lizeng Gao · 2025 · ACS Applied Materials & Interfaces
  29. Gut microbiota metabolites positively impacts chemotherapy effects in colorectal cancer
    Sara Gomes, Sara Granja, Luana A. Osório, Ruth E. Mackay, Fátima Baltazar, Elisabete Silva, Ana Preto · 2026 · Cell Biology and Toxicology
  30. Role of the gut microbiome in shaping drug response in immunocompromised hosts
    Semeh Bejaoui, Federica D’Amico, Silvia Turroni · 2026 · Clinical Microbiology and Infection
  31. Intratumoral Microbiota in Tumor: Current Understandings and Future Perspectives
    Jiawei Chen, Yupan Bai, Lu Shen, Jiacheng Ying, J Q Xu, Jiayin Tang, Yu-Jie Bao · 2026 · MedComm
  32. Characterizing and Exploiting Tumor Microenvironments to Optimize Treatment Outcomes
    Emma H. Allott, Kellie A. Dean, Tracy Robson, Claire L. Meaney · 2021 · Cancers
  33. Effect of antibiotic drug use on outcome and therapy-related toxicity in patients with glioblastoma—A retrospective cohort study
    Linda Götz, Tananeh Ansafi, Michael Gerken, Monika Klinkhammer‐Schalke, Anna Fischl, Markus J. Riemenschneider, Martin Andreas Proescholdt, Elisabeth Bumes, Oliver Kölbl, Nils Ole Schmidt et al. · 2024 · Neuro-Oncology Advances
  34. The interplay between anticancer challenges and the microbial communities from the gut
    Claire Amaris Hobson, Stéphane Bonacorsi, André Baruchel, Olivier Tenaillon, André Birgy · 2022 · European Journal of Clinical Microbiology & Infectious Diseases
  35. Influence of gut microbiota on efficacy and adverse effects of treatment of lymphoproliferative disorders
    Klaudia Zielonka, Marcin Jasiński, Krzysztof Jamroziak · 2022 · Acta Haematologica Polonica
  36. Bacterial biomarkers: new aspects of colorectal tumors diagnosis: reality or fantasy
    Tayebe Shahbazi, Bita Bakhshi, Mohammad Sadegh Fazeli, Elahe Derakhshan-Nezhad · 2023 · European Journal of Cancer Prevention
  37. Differential microbiota network according to colorectal cancer lymph node metastasis stages
    Yeuni Yu, Donghyun Han, Hyomin Kim, Yun Hak Kim, Dongjun Lee · 2023 · Journal of genetic medicine
  38. Unraveling the role of mucins and gut microbiota in gastrointestinal cancers chemoresistance
    A M Vrinda, Muthusamy Thangaraju, S. Asha Nair, Gordon Stanley Howarth, Ramesh Pothuraju · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  39. Near-infrared fluorescent probe for selective detection of nitroreductase and tumor imaging in breast cancer
    Xin Chang, Xiaoyu Wan, Yuanyu Wu, Pinyi Ma, Ying Ge · 2025 · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
  40. The microbial conductor of cancer hallmarks: intratumoral microbiome as a multidimensional oncogenic modulator
    Yibin Wu, Mengyan Zhou, Yiqi Wan, Ke Wei, Shucheng Ma, Lijuan Cheng, Ting Lin, Lan He, Yujun He, Fangliang Zhou · 2026 · Frontiers in Microbiology
  41. Lactobacillus plantarum Zhang-LL alleviates colorectal cancer through the gut microbiome-arachidonic acid metabolism-intratumoral microbiota axis under antibiotic-driven intestinal dysbiosis
    Jingxin Zhu, Xuan Zheng, Xiaodong Song, C.-Y Dai, Junhua Jin, Xiaona Pang, Congyang Cheng, Hongxing ZHANG, Yuanhong Xie · 2026 · Food Bioscience
  42. Impact of the intratumoral resident microbiome on the immune microenvironment of malignant tumors (Review)
    Han Na Oh, Hoon Hur · 2026 · Oncology Reports
  43. Intratumoral Enterobacter hormaechei drives gemcitabine resistance in pancreatic cancer via cdd L ‐mediated drug inactivation
    Jun‐Feng Peng, Meixia Li, Ting Niu, Judong Li, Wei Niu, Minghui Zheng, Quanjiang Ji, Chuan Li, Chenghao Shao, Kan Ding · 2026 · iMeta
  44. The role of the microbiota in hematological malignancies: A narrative review of mechanisms and therapeutic potential
    Atefeh Valaei, Neda Zahmatkesh, Romina Aghaei, M. Maleki, Maryam Meskini, S. D. Siadat · 2026 · new microbes and new infections
  45. Microbiome and cancer: mechanistic insights, diagnostic potential, and therapeutic strategies
    Vivek Kumar, Amit Chaudhary, Mansi Gautam, Pankaj Verma, Meenu Singh · 2026 · Frontiers in Cell and Developmental Biology
  46. Microbiome: pharmacokinetics, pharmacodynamics and drug/xenobiotic interactions
    Matthew Obaineh Ojezele · 2020 · African Journal of Clinical and Experimental Microbiology
  47. Microbiome therapeutics for the cancer management
    Ankita Punetha, Arun Kumar Punetha · 2023 · Elsevier eBooks
  48. Machine Learning-Assisted Optimization of Drug Combinations in Zeolite-Based Delivery Systems for Melanoma Therapy
    Ana Raquel Bertão, Filipe Teixeira, Viktoriya Ivasiv, Píer Parpot, Cristina Almeida Aguiar, António Maurício C. Fonseca, Manuel Bañobre‐López, Fátima Baltazar, Isabel Correia Neves · 2024 · ACS Applied Materials & Interfaces
  49. Metabolites derived from gut microbiota mitigate chemoresistance in pancreatic cancer
    Juan Deng, Dongmei Deng, Bing Wang, Valentina Laura Donati, Adam Enver Frampton, Elisa Giovannetti · 2024 · Expert Review of Gastroenterology & Hepatology
  50. The microbiome and lung cancer: microbial effects on host immune responses and treatment outcomes
    Alexis Bailey, Kerstin K. Leuther, Lary A. Robinson · 2025 · Frontiers in Microbiomes
  51. Suitability of the use of the intraperitoneal route in the in vivo micronucleus test to evaluate the genotoxicity of hair dyes
    Nicola J. Hewitt, Hind Assaf Vandecasteele, Paul Benndorf, Rolf Fautz, Anne V. Fuchs, Karma C. Fussell, Carsten Goebel, Torben König, Fabrice Nesslany, Juliane Werner et al. · 2025 · Regulatory Toxicology and Pharmacology
  52. Effects of Carbon Nanoparticles on Bacteria and Application Potential as Biosensors of Pollution Detection of Ocean Water Carbon Nanoparticles as Antibiotics and Biosensors of Ocean Water
    Akerke Altaikyzy, Haiyan Fan, Yingqiu Xie · 2018 · International Conference on Intelligent Informatics and Biomedical Sciences (ICIIBMS)
  53. Predicting the re-distribution of antibiotic molecules caused by inter-species interactions in microbial communities
    Carlos Reding · 2022 · ISME Communications
  54. A mathematical model for cancer dynamics with treatment and saboteur bacteria
    Anna Geretovszky, Gergely Röst · 2025 · Mathematical Biosciences
  55. Deciphering the intratumor microbiota in malignant gastrointestinal tumors: multifaceted interplay and clinical implications
    Bufu Tang, Y N Lin, Tong Jiang, Yixing Chen, Qianqian Zhao, Shuxuan Wang, Yang Shen, Siwei Wang, Qiqiao Wu, Pengjun Xie et al. · 2026 · Cell Communication and Signaling
  56. Targeting the intratumoral microbiome with advanced nanoplatforms: overcoming therapeutic resistance in cancer
    Zhenzhen Li, Haobo Hou, Weisheng Zhang, Jiale Chen, Ye Lu, Kunjue Shang, Renyuan Tian, Zhouyi Guo Zhouyi Guo, Dantong Shen, Zhiming Liu · 2026 · Chemical Engineering Journal
  57. Modeling cancer with bacteria-integrated tumor microenvironments using biomaterials: Emerging concepts and opportunities
    Keuna Jeon, Uijin Kim, Chang-Hun Ji, Meenakshi Kamaraj, Noah Z. Laird, Zhikun Wang, Hongxiao Yu, Menekşe Ermis, Ruby May A. Sullan, Xiling Shen et al. · 2026 · Materials Today Bio
  58. Microbiome dysbiosis and its modulation in cancer development, prevention and therapy
    Shivendra Dixit, Antonia Welker, Diego Ortiz, Marina Athanasouli, Christoph K. Stein‐Thoeringer · 2026 · Frontiers in Oncology
  59. Antibiotics in Cancer Therapy: Unraveling Mechanisms, Efficacy and Challenges
    K. Nikitha, B. Thanuja · 2024 · International Journal of Innovative Science and Research Technology (IJISRT)
  60. BIOTRANSFORMATION OF THE XENOBIOTICS BY MICROBIOTA OF THE GASTROINTESTINAL TRACT AND ITS CONSEQUENCES FOR HUMANS
    Б. М. Галкін, Т. О. Філіпова · 2020 · Microbiology&Biotechnology
  61. Dysbiosis in Microbiome Leading to Colitis-Associated Cancer
    Priyamvada Priyamvada · 2021 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  62. Diagnostic and Therapeutic Uses of the Microbiome in the Field of Oncology
    Manasa Anipindi, Daniel Bitetto · 2022 · Cureus
  63. Prospective evaluation of the fecal microbiome in dogs with large-cell lymphoma receiving chop chemotherapy
    Jason I. Couto · 2021
  64. Faculty Opinions recommendation of Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.
    Jason M. Crawford · 2017 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  65. The anticancer chemotherapy drug 5-Fluorouracil has positive interaction with antibiotics and can select for antibiotic resistance in Staphylococcus aureus
    Sara R. Henderson, Leila H. Aras, Benjamin Andrew Evans · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Bacteria, Viruses, and the Microbiome
    Hymie Anisman, Shawn P. Hayley, Alexander W. Kusnecov · 2024 · Elsevier eBooks
  67. Editorial: New innovations in therapeutic targets for gastrointestinal toxicity: exploring targets beyond the intestine
    Andrea M. Stringer · 2020 · Current Opinion in Supportive and Palliative Care
  68. Research Progress of Microbiome in Breast Cancer
    曼丽 蘧 · 2022 · Advances in Clinical Medicine
  69. Traditional therapies and their moderation
    Hymie Anisman, Alexander W. Kusnecov · 2022 · Elsevier eBooks
  70. Microbiocenosis of adenocarcinoma tissue in colon cancer patients with different preoperative preparation
    N. I. Simonenko, E. Yu. Zlatnik, N. I. Panova, Oksana G. Shulgina, Aleksey Yu. Maksimov · 2023 · South Russian Journal of Cancer
  71. Drug–Drug Interactions and Drug–Dietary Chemical Interactions
    Mengbi Yang, Yuanfeng Lyu, Zhong Zuo · 2023
  72. Intestinal Microbiota as a Determinant of Effectiveness and Safety of Anticancer Therapy
    Katarzyna Karłowicz-Bodalska, Dorota Bęben, Natalia Janicka, Łukasz Gądek, Grażyna Bodalska · 2024 · Farmacja Polska
  73. Time-Dependent Shifts in Intestinal Bacteriome, Klebsiella Colonization and Incidence of Antibiotic-Resistance Genes after Allogeneic Hematopoietic Stem Cell Transplantation
    Oleg Valerievich Goloshchapov, А. Б. Чухловин, Dmitrii E. Polev, Ю. А. Эйсмонт, Dmitrii Sergeevich Bug, Кусакин Алексей Викторович, Oleg V. Kosarev, Ruslana V. Klementeva, Гостев Владимир Валерьевич, Агеевец Владимир Андреевич et al. · 2024 · Biomedicines
  74. Application and efficacy of intestinal microbiota in pancreatic cancer treatment
    QianNan YING, Jin QU, XiaoRan SUN, XiaoDong LI · 2024 · Scientia Sinica Vitae
  75. Understanding Bacterial Roles in Cancer Chemo-resistance: A Signaling Pathway Mapping Study
    Raushan Kumar Chaudhary, Allen Pinto, Vineeth Mascarenhas, Ashwath Kampa Saliyan, Deepthi Avvaru, Anjana Babu, Uday Venkat Mateti · 2024 · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine
  76. Fecal Microbiota Transplantation and Cancer Immunotherapy: Current Evidence and Future Directions
    Kasra Mokhtarpour, Milad Akbarzadehmoallemkolaei, Nima Rezaei · 2024 · Interdisciplinary cancer research
  77. References
    2024 · Elsevier eBooks
  78. Review Article: Involvement of the Gut Microbiome and Probiotic Interventions in Pediatric Acute Lymphoblastic Leukemia
    Inesa Navasardyan · 2025 · Critical Reviews™ in Oncogenesis
  79. Esophageal microbiome correlates with post-esophagectomy anastomotic leak in cancer patients
    Rawi Naddaf, Haim Shmilovich, Shaqed Carasso, Roni Keshet-David, Rachel Herren, Tal Gefen, Tal Goshen‐Lago, Yaara Zwang, Ilana Livyatan, Noam Shental et al. · 2025 · ESMO Gastrointestinal Oncology
  80. Microbiome and Cancer
    Francesca Righetti, Matteo Massara, Arianna Calcinotto · 2025 · The microbiomes of humans, animals, plants, and the environment
  81. Research Advances in the Association between Gut Microbiota and HER2-Positive Breast Cancer
    腾江 龙 · 2025 · Advances in Clinical Medicine
  82. Role of Microbiota in Pathogenesis of Gastrointestinal Cancers
    Abbes Belkhiri, Nataliya A. Pidkovka · 2025 · Open Medicine Journal
  83. Mechanisms of Different Intestinal Flora in Gastric Cancer
    Yanqing Guo, Qiangqiang Zhang, Tashi Nyima, Yan Hu · 2025 · Journal of Biosciences and Medicines
  84. Zn 2+ -based nanoparticles eliminate intratumoral bacteria to synergistically enhance gemcitabine efficacy in pancreatic cancer therapy
    Rouye Wang, Wenbin Dai, Haojie Chen, Fang Liu, Weifeng Liu, Jian Ji, Qiao Jin · 2025 · Nano Research
  85. Additional file 4 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
    Francesca Benedetti, Emmanuel F. Mongodin, Badger, Jonathan H., Arshi Munawwar, Ashley Cellini, Weirong Yuan, Giovannino Silvestri, Kraus, Carl N., Marini, Simone, Chozha Vendan Rathinam et al. · 2024 · Figshare
  86. Additional file 3 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
    Francesca Benedetti, Emmanuel F. Mongodin, Jonathan H. Badger, Arshi Munawwar, Ashley Cellini, Weirong Yuan, Giovannino Silvestri, Kraus, Carl N., Marini, Simone, Chozha Vendan Rathinam et al. · 2024 · Figshare
  87. Additional file 1 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
    Francesca Benedetti, Emmanuel F. Mongodin, Badger, Jonathan H., Arshi Munawwar, Ashley Cellini, Weirong Yuan, Giovannino Silvestri, Kraus, Carl N., Marini, Simone, Chozha Vendan Rathinam et al. · 2024 · Figshare
  88. Additional file 1 of Breast cancer: the first comparative evaluation of oncobiome composition between males and females
    Elena Niccolai, Baldi, Simone, Giulia Nannini, Francesca Gensini, Papi, Laura, Vania Vezzosi, Simonetta Bianchi, Lorenzo Orzalesi, Matteo Ramazzotti, Amedei, Amedeo · 2024 · Figshare
  89. Additional file 5 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
    Francesca Benedetti, Emmanuel F. Mongodin, Badger, Jonathan H., Arshi Munawwar, Ashley Cellini, Weirong Yuan, Giovannino Silvestri, Kraus, Carl N., Simone Marini, Chozha Vendan Rathinam et al. · 2024 · Figshare
  90. Additional file 2 of Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU
    Francesca Benedetti, Emmanuel F. Mongodin, Badger, Jonathan H., Arshi Munawwar, Ashley Cellini, Weirong Yuan, Giovannino Silvestri, Kraus, Carl N., Simone Marini, Chozha Vendan Rathinam et al. · 2024 · Figshare
  91. The Human Microbiome: An Overview of Microbial Mechanisms, Diagnostics, and Therapeutic Modulation in Cancer
    Ismail Ibrahim Al-Janabi · 2026 · Al-Rafidain Journal of Medical Sciences
  92. Beyond Sterility: the Urinary Microbiome in Bladder Cancer Carcinogenesis and Treatment
    Stephanie L. Aron, Margaret Frances Meagher, Sarah Azari, Benjamin H. Baker, Ryan Nasseri, Aditya Bagrodia, Tyler Francis Stewart, Michael Andre Liss, Amirali Salmasi · 2026 · Current Urology Reports
  93. Green Synthesized Silver Nanoformulation Using Rhubarb Extract for Antibacterial and Anticancer Therapy in Infection-Associated Breast Cancer Mice
    Li-Juan Kang, Rui Ma, Xiao-Bo Zhao, Yangxia Han, Yan-Ping Shi, Wei Ha · 2026 · ACS Applied Materials & Interfaces
  94. Impacts de la chimiothérapie sur le microbiote intestinal à travers l'exemple du pemetrexed sur les modèles murins PDX
    Cindy Pensec · 2018
  95. Insights into the bidirectional interactions between the gut microbiota and the xenobiotic receptors CAR and PXR
    Sharon Ann Barretto · 2019 · theses.fr (ABES)
  96. Etude de l’effet d’un traitement par Faecalibacterium prausnitzii dans un modèle pré-clinique d’atteintes colorectales radio-induites
    Alexia Lapière · 2020 · theses.fr (ABES)
  97. Analyse de l'efficacité et de la toxicité de l’irinotecan : Méta-analyses sur données individuelles dans le cancer gastrique avancé ou métastatique. Développements cliniques et méthodologiques
    Ali N. Chamseddine · 2021
  98. Nanovecteurs innovants pour la délivrance de ferrocifènes, dans le traitement du cancer du poumon
    Abdallah Ladaycia · 2022
  99. Effet des inhibiteurs de la pompe à proton gastrique sur la réponse anti tumorale aux inhibiteurs de point de contrôle immunitaire
    Eloïse Ramel · 2024 · theses.fr (ABES)
  100. Microbiome influence on cancer
    Fatima Khan, Shariq Ahmed, Uzma Tayyaba · 2026 · Elsevier eBooks